Intestinal Microbiota Distinguish Gout Patients from Healthy Humans.
Guo Z, Zhang J, Wang Z, Ang KY, Huang S, Hou Q, Su X, Qiao J, Zheng Y, Wang L, Koh E, Danliang H, Xu J, Lee YK, Zhang H. · 2016
Read Intestinal Microbiota Distinguish Gout Patients from Healthy Humans. by Guo Z, Zhang J, Wang Z, Ang KY, Huang S, Hou Q, Su X, Qiao J, Zheng Y, Wang L, Koh E, Danliang H, Xu J, Lee YK, Zhang H. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4757479.txt.
Introduction
Zhuang Guo leads a twelve-author study in Scientific Reports in 2016 that reads gut microbes to tell gout patients from healthy people. Gout is a painful joint disease tied to uric acid build-up, and blood tests for it can miss cases or lag behind. The team asked whether stool microbes carry a clearer signal.
From 33 healthy people and 35 patients, they found the gut mix split sharply. Two Bacteroides species ran high in gout, while two helpful species ran low. Gene reads showed faults in uric acid breakdown and in making a gut-soothing acid. A test built on 17 microbe markers sorted a fresh group with close to nine in ten right. The team proposes a stool-based index as a gentle, non-invasive check.
Catalog record
| CREATOR | Guo Z, Zhang J, Wang Z, Ang KY, Huang S, Hou Q, Su X, Qiao J, Zheng Y, Wang L, Koh E, Danliang H, Xu J, Lee YK, Zhang H. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Intestinal Microbiota Distinguish Gout Patients from Healthy Humans By Zhuang Guo, Jiachao Zhang, Zhanli Wang, Kay Ying Ang, Shi Huang, Qiangchuan Hou, Xiaoquan Su, Jianmin Qiao, Yi Zheng, Lifeng Wang, Eileen Koh, Ho Danliang Published in: Scientific Reports DOI: 10.1038/srep20602 ABSTRACT Abstract Current blood-based approach for gout diagnosis can be of low sensitivity and hysteretic. Here via a 68-member cohort of 33 healthy and 35 diseased individuals, we reported that the intestinal microbiota of gout patients are highly distinct from healthy individuals in both organismal and functional structures. In gout, Bacteroides caccae and Bacteroides xylanisolvens are enriched yet Faecalibacterium prausnitzii and Bifidobacterium pseudocatenulatum depleted. The established reference microbial gene catalogue for gout revealed disorder in purine degradation and butyric acid biosynthesis in gout patients. In an additional 15-member validation-group, a diagnosis model via 17 gout-associated bacteria reached 88.9% accuracy, higher than the blood-uric-acid based approach. Intestinal microbiota of gout are more similar to those of type-2 diabetes than to liver cirrhosis, whereas depletion of Faecalibacterium prausnitzii and reduced butyrate biosynthesis are shared in each of the metabolic syndromes. Thus the Microbial Index of Gout was proposed as a novel, sensitive and non-invasive strategy for diagnosing gout via fecal microbiota. Gout is an auto-inflammatory disease caused by a disorder in purine metabolism and the resulted chronic elevation of blood uric acid (i.e., hyperuricemia)1. With increased intake of high protein food in many societies, incidents of gout has been expanding at an alarm rate worldwide2. In 2011, prevalence of gout in US adults is about 3.9%, and that of hyperuricemia which is a precondition for developing gout reached up to 21%3. In UK, prevalence of gout has risen to 2.5% of the general population in 2012, an increase of 63.9% since 19974. In China, gout was previously extremely rare, yet the number of confirmed cases has reached 75 million by the end of 20105. Despite the expanding prevalence of the disease, accurate diagnosis remains a challenge. Pathogenesis of gout is closely related to the increased accumulation and the reduced excretion of uric acid (the end product of purine metabolism). The resulted deposition of uric acid salt crystals in joints and the surrounding tissues lead to acute joint pain6. Therefore, the two symptoms of (i) deposition of uric acid salt combined with acute pain in and around joints and (ii) increase in uric acid level in blood, are presently the clinical diagnostic criteria for gout7. The latter, termed the blood uric acid value, is considered as the major diagnostic criteria in current clinical practice, as it is quantifiable. However the blood uric acid index seems to be hysteretic in a large part and not sufficiently sensitive8. Individuals suffered from gout are frequently in a stressed state, which causes reflective secretion of adrenocorticotrophic hormone to compel the discharge of uric acid by kidney9. Consequently, there can be no significant rise of uric acid for most early-onset gout patients8. Therefore method development for early diagnosis of gout has been of high priority. Healthy humans excrete uric acid in two main ways, with 70% excreted through the kidney and the remaining 30% via the intestine10. Human intestine homes a huge number of microbes collectively known as intestinal microbiota, whose activities are linked to numerous host functions11,12,13,14,15. The intestinal microbiota are known to participate in metabolism of purine and uric acid. For example, in the oxidative metabolism of purine, the responsible enzyme xanthine dehydrogenase can be secreted by the Escherichia coli group of human intestinal bacteria16,17. In uric acid catabolism, uricase, allantoinase and allantoicase activities can sequentially degrade uric acid to 5-hydroxyisourate, allantoin, allantoate and eventually to urea. Synthesis of these enzymes was found vigorous in Lactobacillus and Pseudomonas, both common members of human intestinal microbiota18. Moreover transport protein of uric acid were found secreted by various indigenous microbes in human gut19. Therefore, we hypothesize that the intestinal microbiota can potentially serve as proxy to probe uric acid metabolism in the host for the purpose of diagnosis or prognosis. To test this hypothesis, here we designed a cross-sectional study in an 83-member Chinese cohort that consists of both gout patients and healthy individuals. The taxonomic structure of their intestinal microbiota was determined by 16S rRNA gene pyrosequencing, and the functional profile of the corresponding microbiome was determined by shotgun metagenomic sequencing. Profound difference in microbial taxonomic and functional features was discovered between gout patients and healthy individuals. A microbiota-based model based on such difference was established and shown to diagnose gout at 88.9% accuracy. RESULTS Intestinal microbiota altered profoundly in gout patients The study cohort includes 83 Chinese adults (Table 1, Supplementary Table 1). The gout group consists of 35 adult patients who were clinically diagnosed by endocrinologists as gout based on blood uric acids, claim of joint pains and other parameters. The healthy group which serves as control consists of 33 healthy adults. An additional, 15-member group for model validation purpose consists of 6 gout patients and 9 healthy individuals. For each of the collectively 83 subjects, organismal structure of intestinal microbiota was analyzed by sequencing 16S rRNA gene amplicons, which revealed for each microbiota on average 202 operational taxonomic units (OTUs) from averagely 6402 reads (Supplementary Table 2). To characterize the functional profiles of microbiota, 16 from the gout group, 18 from the healthy group and 5 from the validation group were randomly selected for whole-metagenome shotgun sequencing, yielding 371.2 Giga base (Gb) of pair-end reads (averagely 59,681,612 high-quality reads for each microbiota; Supplementary Table 3). [Table: Sample information and blood index.] Between the gout group and the healthy group, no significant difference was found for the factors of age, gender or BMI. However, among the array of blood indices, significant differences (P < 0.001, Wilcoxon rank-sum test) were detected between the two groups in blood uric acid value, total bilirubin, glutamic-pyruvic transaminase (GPT), glutamic oxalacetic transaminase (GOT) and urea nitrogen level (Fig. 1A; Supplementary Table 1). Intriguingly, in the gout group, the blood uric acid values of patients 14, 27, 39 and 60 were lower than other patients, which is consistent with the notion of insufficient sensitivity of the blood uric acid index for diagnosing gout in certain patients8. [Figure: The composition of gut microbiota alters profoundly in gout patients.(A) The uric acid values in the gout patients, healthy (control) and validation groups. (B) A principal component (PCoA) score plot based on weighted UniFrac metrics for all participants. Each point represents the composition of the intestinal microbiota of one participant.] To test whether any difference in organismal structure of intestinal microbiota was present, Principal Coordinates Analysis (PCoA) was performed based on the weighted Unifrac distances of 16S rRNA sequence profiles at the genus level. A significant reduction was observed in α diversity of intestinal microbiota from the gout group as compared to those from the healthy group (P < 0.01, Wilcoxon rank-sum test; Supplementary Table 4), suggesting that a lower microbial diversity in the intestine was associated with gout. Moreover, intestinal microbiota from the gout group and the healthy group were highly distinct in organismal structure, with the subjects forming two clusters that respectively corresponded to the two groups (Fig. 1B, upper panel), and significant separation (P < 0.001) in PC 1 was observed